Due to health issues, this site is no longer maintained and will be shut down shortly.

RVPHW Reviva Pharmaceuticals Holdings, Inc. - Warrants

Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.  This security was issued by Reviva Pharmaceuticals Holdings, Inc., whose common stock symbol is RVPH.

$0.97  0.00 (0.00%)
As of 03/24/2023 00:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Warrants
Category3:  Operating Companies
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/18/2018
Outstanding shares:  6,325,000
Average volume:  8,553
Market cap:   $80,749,340
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy